1. Advances in MUC1-Mediated Breast Cancer Immunotherapy
   Zhifeng Li et al, 2022, Biomolecules CrossRef
2. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
   Didier Dréau et al, 2019, Frontiers in Oncology CrossRef